Statistical and reporting code for a single-center retrospective cohort study of vaginal gestrinone in endometriosis, characterizing its endocrine-metabolic profile, bleeding pattern, tolerability and treatment persistence. No patient data …
Statistical and reporting code for a single-center retrospective cohort study of vaginal gestrinone in endometriosis, characterizing its endocrine-metabolic profile, bleeding pattern, tolerability and treatment persistence. No patient data …
Endometriosis is increasingly recognized as a chronic systemic disorder extending beyond the classical estrogen-dependent paradigm, integrating metabolic, immune, fibrotic, and nociceptive pathways that sustain lesion persistence and refrac…
INTRODUCTION: Gestrinone is an androgenic progestin derived from 19-nortestosterone, in use for four decades in endometriosis and other estrogen-dependent conditions. It has largely disappeared from contemporary progestin taxonomies and is …
Background: The management of endometriosis-associated pain has traditionally focused on analgesic efficacy. However, with high-level evidence demonstrating therapeutic equivalence among principal hormonal classes, the paradigm has shifted …
Background: The management of endometriosis-associated pain has traditionally focused on analgesic efficacy. However, with high-level evidence demonstrating therapeutic equivalence among principal hormonal classes, the paradigm has shifted …